Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 1
1962 1
1969 2
1974 4
1975 4
1976 1
1977 5
1978 3
1979 3
1980 2
1981 1
1982 5
1983 4
1984 8
1985 6
1986 10
1987 3
1988 7
1989 5
1990 8
1991 2
1992 6
1993 3
1994 2
1995 4
1996 5
1997 4
1998 5
1999 4
2000 11
2001 12
2002 6
2003 12
2004 10
2005 12
2006 12
2007 7
2008 15
2009 10
2010 10
2011 14
2012 20
2013 9
2014 17
2015 16
2016 16
2017 18
2018 23
2019 34
2020 32
2021 20
2022 16
2023 31
2024 13
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

512 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
Nrf2/Keap1/ARE signaling: Towards specific regulation.
Ulasov AV, Rosenkranz AA, Georgiev GP, Sobolev AS. Ulasov AV, et al. Among authors: sobolev as. Life Sci. 2022 Feb 15;291:120111. doi: 10.1016/j.lfs.2021.120111. Epub 2021 Oct 31. Life Sci. 2022. PMID: 34732330 Free PMC article. Review.
Transcription factors: Time to deliver.
Ulasov AV, Rosenkranz AA, Sobolev AS. Ulasov AV, et al. Among authors: sobolev as. J Control Release. 2018 Jan 10;269:24-35. doi: 10.1016/j.jconrel.2017.11.004. Epub 2017 Nov 4. J Control Release. 2018. PMID: 29113792 Review.
Selected strategies to fight pathogenic bacteria.
Plotniece A, Sobolev A, Supuran CT, Carta F, Björkling F, Franzyk H, Yli-Kauhaluoma J, Augustyns K, Cos P, De Vooght L, Govaerts M, Aizawa J, Tammela P, Žalubovskis R. Plotniece A, et al. Among authors: sobolev a. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2155816. doi: 10.1080/14756366.2022.2155816. J Enzyme Inhib Med Chem. 2023. PMID: 36629427 Free PMC article. Review.
Handling Metadata in a Neurophysiology Laboratory.
Zehl L, Jaillet F, Stoewer A, Grewe J, Sobolev A, Wachtler T, Brochier TG, Riehle A, Denker M, Grün S. Zehl L, et al. Among authors: sobolev a. Front Neuroinform. 2016 Jul 19;10:26. doi: 10.3389/fninf.2016.00026. eCollection 2016. Front Neuroinform. 2016. PMID: 27486397 Free PMC article.
NMR-Based Approaches in the Study of Foods.
Sobolev AP, Ingallina C, Spano M, Di Matteo G, Mannina L. Sobolev AP, et al. Molecules. 2022 Nov 15;27(22):7906. doi: 10.3390/molecules27227906. Molecules. 2022. PMID: 36432006 Free PMC article. Review.
A proteometabolomic study of Actinidia deliciosa fruit development.
Salzano AM, Sobolev A, Carbone V, Petriccione M, Renzone G, Capitani D, Vitale M, Minasi P, Pasquariello MS, Novi G, Zambrano N, Scortichini M, Mannina L, Scaloni A. Salzano AM, et al. Among authors: sobolev a. J Proteomics. 2018 Feb 10;172:11-24. doi: 10.1016/j.jprot.2017.11.004. Epub 2017 Nov 11. J Proteomics. 2018. PMID: 29133123 No abstract available.
512 results